{"filing":{"accession_number":"0000310764-26-000041","cik":"0000310764","ticker":"SYK","company_name":"STRYKER CORP","form":"8-K","filing_date":"2026-06-26","report_date":null,"primary_document":"syk-20260626.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/310764/000031076426000041/syk-20260626.htm"},"events":[{"id":14185,"run_id":12621,"accession_number":"0000310764-26-000041","anchor_item_number":"8.01","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"summary":"Stryker announced a material reorganization of its business structure in Q1 2026, combining the orthopaedic instruments portfolio with Mako and enabling technologies into a new \"Ortho Tech\" business. This restructuring changes the company's segment reporting from three segments to two (MedSurg and Neurotechnology, and Orthopaedics), affecting how financial results are presented and analyzed. While the filing emphasizes this is a \"recast\" rather than a restatement, the organizational restructuring and resulting segment reporting changes are material operational events that would affect investor understanding of the company's business structure and performance metrics.","company_name":"STRYKER CORP","ticker":"SYK","filing_date":"2026-06-26","form":"8-K","submitted_at":null,"items":[{"id":11543,"accession_number":"0000310764-26-000041","item_number":"8.01","item_title":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"Stryker announced a material reorganization of its business structure in Q1 2026, combining the orthopaedic instruments portfolio with Mako and enabling technologies into a new \"Ortho Tech\" business. This restructuring changes the company's segment reporting from three segments to two (MedSurg and Neurotechnology, and Orthopaedics), affecting how financial results are presented and analyzed. While the filing emphasizes this is a \"recast\" rather than a restatement, the organizational restructuring and resulting segment reporting changes are material operational events that would affect investor understanding of the company's business structure and performance metrics.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-26T19:46:38.871550+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":11543,"accession_number":"0000310764-26-000041","item_number":"8.01","item_title":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"Stryker announced a material reorganization of its business structure in Q1 2026, combining the orthopaedic instruments portfolio with Mako and enabling technologies into a new \"Ortho Tech\" business. This restructuring changes the company's segment reporting from three segments to two (MedSurg and Neurotechnology, and Orthopaedics), affecting how financial results are presented and analyzed. While the filing emphasizes this is a \"recast\" rather than a restatement, the organizational restructuring and resulting segment reporting changes are material operational events that would affect investor understanding of the company's business structure and performance metrics.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-26T19:46:38.871550+00:00","company_name":"STRYKER CORP","ticker":"SYK","filing_date":"2026-06-26"}]}